G. Delander

发表

Involvement of A2 adenosine receptors in spinal mechanisms of antinociception.

G. Delander, C. Hopkins, 1987, European journal of pharmacology.

Distribution of antinociceptive adenosine a1 receptors in the spinal cord dorsal horn, and relationship to primary afferents and neuronal subpopulations

B. Fredholm, G. Schulte, B. Robertson, 2003, Neuroscience.

Role of spinal mu opioid receptors in the development of morphine tolerance and dependence.

P. Portoghese, A. Takemori, G. Delander, 1984, The Journal of pharmacology and experimental therapeutics.

Spinal antagonism of tolerance and dependence induced by systemically administered morphine.

A. Takemori, G. Delander, 1983, European journal of pharmacology.

Involvement of adenosine in antinociception produced by spinal or supraspinal receptor-selective opioid agonists: dissociation from gastrointestinal effects in mice.

H. Mosberg, F. Porreca, G. Delander, 1992, Journal of Pharmacology and Experimental Therapeutics.

Center for the Advancement of Pharmacy Education 2013 Educational Outcomes

Melissa S Medina, Cecilia M. Plaza, D. Beck, 2013, American Journal of Pharmaceutical Education.

Temporal changes in spinal cord expression of mRNA for substance P, dynorphin and enkephalin in a model of chronic pain.

B. Fredholm, E. Brodin, E. Schött, 1997, Acta Physiologica Scandinavica.

Increased nociceptive response in mice lacking the adenosine A1 receptor

B. Fredholm, Xiao-jun Xu, Z. Wiesenfeld‐Hallin, 2005, Pain.

Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opioid agonist-induced antinociception in mice.

G. Keil, G. Delander, 1994, European journal of pharmacology.

Behavior induced by putative nociceptive neurotransmitters is inhibited by adenosine or adenosine analogs coadministered intrathecally.

G. Delander, J. Wahl, 1988, The Journal of pharmacology and experimental therapeutics.

Spinally-mediated antinociception is induced in mice by an adenosine kinase-, but not by an adenosine deaminase-, inhibitor.

G. Keil, G. Delander, 1992, Life sciences.

Synthesis and opioid activity of 2-substituted dynorphin A-(1-13) amide analogues.

T. F. Murray, J. V. Aldrich, G. Delander, 2009, International journal of peptide and protein research.

Preparing pharmacy graduates for traditional and emerging career opportunities.

S. Meyer, R. Nemire, E. F. Fiese, 2009, American journal of pharmaceutical education.

Report of the 2012-2013 Academic Affairs Standing Committee: Revising the Center for the Advancement of Pharmacy Education (CAPE) Educational Outcomes 2013

Melissa S Medina, Cecilia M. Plaza, D. Beck, 2013, American Journal of Pharmaceutical Education.

An Interprofessional Approach to Reducing the Risk of Falls Through Enhanced Collaborative Practice

E. Eckstrom, M. Neal, V. Cotrell, 2016, Journal of the American Geriatrics Society.

Spinal adenosine modulates descending antinociceptive pathways stimulated by morphine.

G. Delander, C. Hopkins, 1986, The Journal of pharmacology and experimental therapeutics.

Altered sensory behaviors in mice following manipulation of endogenous spinal adenosine neurotransmission.

G. Keil, G. Delander, 1996, European journal of pharmacology.

Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors.

G. Keil, G. Delander, 1995, The Journal of pharmacology and experimental therapeutics.

Synthesis and opioid activity of dynorphin A-(1-13)NH2 analogues containing cis- and trans-4-aminocyclohexanecarboxylic acid.

T. F. Murray, J. V. Aldrich, G. Delander, 1993, Journal of medicinal chemistry.

Rules of the Road

Gary E. DeLander, G. Delander, 2012, American Journal of Pharmaceutical Education.

Spinal expression of mRNA for immediate early genes in a model of chronic pain.

B. Fredholm, E. Brodin, E. Schött, 1997, Acta physiologica Scandinavica.

Descending systems activated by morphine (ICV) inhibit kainic acid (IT)-induced behavior

G. Delander, J. Wahl, 1991, Pharmacology Biochemistry and Behavior.

Morphine (intracerebroventricular) activates spinal systems to inhibit behavior induced by putative pain neurotransmitters.

G. Delander, J. Wahl, 1989, The Journal of pharmacology and experimental therapeutics.

Interdependence of spinal adenosinergic, serotonergic and noradrenergic systems mediating antinociception

G. Delander, C. Hopkins, 1987, Neuropharmacology.

Synthesis and opioid activity of [D-Pro10]dynorphin A-(1-11) analogues with N-terminal alkyl substitution.

T. F. Murray, J. V. Aldrich, W. Schmidt, 1997, Journal of medicinal chemistry.

N-terminal alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are highly selective for kappa-opioid receptors.

T. F. Murray, J. V. Aldrich, G. Delander, 1992, Journal of medicinal chemistry.

Rules of the Road

G. Delander, 2012, American Journal of Pharmaceutical Education.

In vivo characterization of phencyclidine/σ agonist-mediated inhibition of nociception

G. Delander, J. Wahl, 1989 .

Center for the Advancement of Pharmacy Education 2013 Educational Outcomes

Melissa S Medina, Cecilia M. Plaza, D. Beck, 2013, American Journal of Pharmaceutical Education.

Optimizing Professional Education in Pharmacy: Are the Ingredients as Important as the Recipe?

G. Delander, 2005, American Journal of Pharmaceutical Education.

Falls prevention education: Interprofessional training to enhance collaborative practice

M. Neal, K. Lasater, Glenise McKenzie, 2017, Gerontology & geriatrics education.

Lessons From a Recovering Department Chair

G. Delander, 2017, American Journal of Pharmaceutical Education.